Inhibition of insulin and glucagon secretion by somatostatin: are there indirect effects?
D000818:Animals; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005934:Glucagon / Q000378:metabolism*; D006503:Hepatic Veins; D007261:Infusions, Intra-Arterial; D007263:Infusions, Parenteral; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism; D010179:Pancreas / Q000098:blood supply; D013004:Somatostatin / Q000008:administration & dosage / Q000494:pharmacology*
D007328:Insulin; D013004:Somatostatin; D005934:Glucagon